Glycemia Reduction in Type 2 Diabetes — Glycemic Outcomes

Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes

(2022)   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of central laboratory HbA1c measurements obtained from a capillary collection versus a standard venous whole blood collection in the GRADE and EDIC studies

(2021) David M. Nathan et al.   PLoS One

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021

(2020)   DIABETES CARE

6. Glycemic Targets: Standards of Medical Care in Diabetes—2021

(2020)   DIABETES CARE

Baseline Characteristics of Randomized Participants in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

(2019) Deborah J. Wexler et al.   DIABETES CARE

Closed testing of each group versus the others combined in a multiple group analysis

(2019) John M Lachin et al.   Clinical Trials

2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2019) John B. Buse et al.   DIABETES CARE

Masthead

(2018)   Canadian Journal of Diabetes

Economic Costs of Diabetes in the U.S. in 2017

(2018)   DIABETES CARE

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2018) Melanie J. Davies et al.   DIABETES CARE

Influence of Race, Ethnicity and Social Determinants of Health on Diabetes Outcomes

(2016) Rebekah J. Walker et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Self-Care Disparities Among Adults with Type 2 Diabetes in the USA

(2016) Lindsay Satterwhite Mayberry et al.   Current Diabetes Reports

A Network Meta-analysis Comparing Exenatide Once Weekly with Other GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus

(2016) Sheena Kayaniyil et al.   Diabetes Therapy

A Network Meta-analysis Comparing Exenatide Once Weekly with Other GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus

(2016) Sheena Kayaniyil et al.   Diabetes Therapy

On the restricted mean survival time curve in survival analysis

(2015) Lihui Zhao et al.   BIOMETRICS

Rationale and Design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

(2013) D. M. Nathan et al.   DIABETES CARE